Cerebain Initiates Repositioning and Review of Business and Corporate Strategic Growth Plan, engages NMS Consulting, Inc.

Cerebain Biotech Corp. (CBBT), announced that it has initiated a repositioning and review of its overall business and corporate strategic plan to maximize shareholder value.